Conexeu Sciences is trading at $9.50, up 6.74% in pre-market, with the move appearing driven mainly by momentum and broader risk-on sentiment.
- Available coverage identified no new company-specific announcement for August 17, 2026, and does not establish a fresh catalyst.
- Recent attention followed Conexeu’s August 14–16 tissue-regeneration symposium presentation.
- Conexeu Sciences gained sharply across recent sessions, rising 11.67% on August 14 and 9.03% on August 13; Nasdaq futures were up 0.55%.